Basecamp Research links EDEN models to Anthropic’s Claude Science

The collaboration enables scientists to bypass months of empirical laboratory work. In tests conducted with the University of Pennsylvania, 97% of antibiotic peptides generated by EDEN proved active against WHO-designated priority pathogens. Notably, one candidate, EDEN-7, demonstrated efficacy comparable to last-line antibiotics against multidrug-resistant Acinetobacter baumannii, even without further iterative engineering.

Beyond antibiotic discovery, the platform streamlines vaccine development by identifying proteins most likely to trigger immune responses. This capability leverages BaseData, a massive biological dataset sourced from over 200 global locations, ranging from deep-sea sediment to polar ice. Unlike models trained on narrow, well-studied organisms, EDEN utilizes a repository containing over 10 billion new genes. Basecamp Research plans to expand this foundation 100-fold via the Trillion Gene Atlas project, supported by partners including NVIDIA and PacBio, while maintaining strict data provenance and benefit-sharing agreements with the source nations.